Biosimilars G-CSF versus originator G-CSF in post allotransplant recovery. A case-control study

Am J Hematol. 2016 Feb;91(2):E7-8. doi: 10.1002/ajh.24250.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allografts
  • Biosimilar Pharmaceuticals / administration & dosage
  • Biosimilar Pharmaceuticals / therapeutic use*
  • Case-Control Studies
  • Filgrastim / administration & dosage
  • Filgrastim / therapeutic use*
  • Hematologic Agents / administration & dosage
  • Hematologic Agents / therapeutic use*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Neutropenia / etiology
  • Neutropenia / prevention & control*
  • Treatment Outcome

Substances

  • Biosimilar Pharmaceuticals
  • Hematologic Agents
  • Filgrastim